Updated June 7, 2024
EOC represents a group of heterogeneous disease entities. Five major categories of EOC exist, with differing cellular origins, hereditary implications, molecular alterations and potential for targeted therapies (Figure 1). In general, to promote consistency and uniformity, pathology review by a BC Cancer accredited tumor group pathologist is recommended.
** Other rare subtypes not listed include carcinosarcoma (Malignant Mixed Mullerian Tumor, MMMT), undifferentiated carcinoma, mesonephric-like adenocarcinoma of the ovary and malignant Brenner tumor.
Click
here to download a larger version of Figure 1.
